JPS59193888A - フロ−（３，４−ｃ）−ピリジン誘導体、その製造法及びそれを含有する医薬 - Google Patents

フロ−（３，４−ｃ）−ピリジン誘導体、その製造法及びそれを含有する医薬

Info

Publication number
JPS59193888A
JPS59193888A JP59066853A JP6685384A JPS59193888A JP S59193888 A JPS59193888 A JP S59193888A JP 59066853 A JP59066853 A JP 59066853A JP 6685384 A JP6685384 A JP 6685384A JP S59193888 A JPS59193888 A JP S59193888A
Authority
JP
Japan
Prior art keywords
group
carbon atoms
alkoxy
groups
carbon
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP59066853A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0556353B2 (enExample
Inventor
アンドレ・エサヌ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ipsen Pharma SAS
Original Assignee
Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB838327815A external-priority patent/GB8327815D0/en
Application filed by Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS filed Critical Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS
Publication of JPS59193888A publication Critical patent/JPS59193888A/ja
Publication of JPH0556353B2 publication Critical patent/JPH0556353B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
JP59066853A 1983-04-05 1984-04-05 フロ−（３，４−ｃ）−ピリジン誘導体、その製造法及びそれを含有する医薬 Granted JPS59193888A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB8309165 1983-04-05
GB8309165 1983-04-05
GB838327815A GB8327815D0 (en) 1983-10-18 1983-10-18 Furo-(3 4-c)-pyridine derivatives
GB8327815 1983-10-18

Publications (2)

Publication Number Publication Date
JPS59193888A true JPS59193888A (ja) 1984-11-02
JPH0556353B2 JPH0556353B2 (enExample) 1993-08-19

Family

ID=26285725

Family Applications (1)

Application Number Title Priority Date Filing Date
JP59066853A Granted JPS59193888A (ja) 1983-04-05 1984-04-05 フロ−（３，４−ｃ）−ピリジン誘導体、その製造法及びそれを含有する医薬

Country Status (29)

Country Link
US (1) US4581363A (enExample)
JP (1) JPS59193888A (enExample)
KR (1) KR900005518B1 (enExample)
AU (1) AU582113B2 (enExample)
CA (1) CA1257269A (enExample)
CH (1) CH660191A5 (enExample)
DE (1) DE3412885C2 (enExample)
DK (1) DK157931C (enExample)
DZ (1) DZ629A1 (enExample)
EG (1) EG18150A (enExample)
ES (1) ES531285A0 (enExample)
FI (1) FI76804C (enExample)
FR (2) FR2543956B1 (enExample)
GR (1) GR79577B (enExample)
HK (1) HK11187A (enExample)
IE (1) IE57424B1 (enExample)
IL (1) IL71243A (enExample)
IN (1) IN160104B (enExample)
IT (1) IT1173770B (enExample)
LU (1) LU85262A1 (enExample)
MA (1) MA20084A1 (enExample)
MX (1) MX167397B (enExample)
MY (1) MY8600664A (enExample)
NL (1) NL190328C (enExample)
NO (1) NO161802C (enExample)
NZ (1) NZ207552A (enExample)
OA (1) OA07699A (enExample)
PT (1) PT78361B (enExample)
SE (1) SE458362B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02504394A (ja) * 1988-04-06 1990-12-13 ソシエテ・ド・コンセイユ・ド・ルシエルシエ・エ・ダアツプリカーシヨン・シヤンテイフイツク・（エス．セー．エール．アー．エス） フロ〔３，４‐ｃ〕ピリジン鏡像体の立体特異的製造方法、かくして得られた化合物及びこれの製薬組成物

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4735950A (en) * 1983-04-05 1988-04-05 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S) Furo-(3,4-C)-pyridine derivatives and therapeutic composition containing the same
GB8427218D0 (en) * 1984-10-27 1984-12-05 Scras Pyridine derivatives
DE3990349T1 (de) * 1988-04-06 1990-04-26 Scras Stereospezifisches verfahren zur herstellung von enantiomeren von furo(3,4-c)pyridin, so erhaltene verbindungen und therapeutische zusammensetzungen auf basis dieser verbindungen
GB8917168D0 (en) * 1989-07-27 1989-09-13 Scras Asymmetric synthesis of furo(3,4-c)pyridine derivatives
US5130252A (en) * 1990-05-14 1992-07-14 Synthetech, Inc. Resolution of furopyridine enantiomers and synthetic precursors thereof
US6043259A (en) * 1998-07-09 2000-03-28 Medicure Inc. Treatment of cardiovascular and related pathologies
ATE306489T1 (de) 1999-03-08 2005-10-15 Medicure Inc Pyridoxal-analoge zur behandlung von störungen ausgelöst durch einen vitamin b6 mangel
WO2001003682A2 (en) 1999-07-13 2001-01-18 Medicure Inc. Use of pyridoxin derivatives for the treatment of diabetes and related complications
JP2003507418A (ja) 1999-08-24 2003-02-25 メディキュア インターナショナル インコーポレイテッド 心血管疾患とその関連疾患の治療
PT1268498E (pt) 2000-02-29 2005-07-29 Medicure Int Inc Fosfonatos cardioprotectores
US7442689B2 (en) * 2000-02-29 2008-10-28 Medicure International Inc. Cardioprotective phosphonates and malonates
JP2003528146A (ja) 2000-03-28 2003-09-24 メディキュア インターナショナル インコーポレイテッド 脳血管疾患の治療
US6417204B1 (en) 2000-07-07 2002-07-09 Medicure International Inc. Pyridoxine AMD pyridoxal analogues: cardiovascular therapeutics
US6548519B1 (en) 2001-07-06 2003-04-15 Medicure International Inc. Pyridoxine and pyridoxal analogues: novel uses
US6897228B2 (en) * 2000-07-07 2005-05-24 Medicure International Inc. Pyridoxine and pyridoxal analogues: new uses
US20040121988A1 (en) * 2001-03-28 2004-06-24 Medicure International Inc. Treatment of cerebrovascular disease
US20040186077A1 (en) * 2003-03-17 2004-09-23 Medicure International Inc. Novel heteroaryl phosphonates as cardioprotective agents
AU2005259735A1 (en) * 2004-07-07 2006-01-12 Medicure International Inc. Combination therapies employing platelet aggregation drugs
US20070060549A1 (en) * 2004-08-10 2007-03-15 Friesen Albert D Combination therapies employing ace inhibitors and uses thereof for the treatment of diabetic disorders
US20060094749A1 (en) * 2004-10-28 2006-05-04 Medicure International Inc. Substituted pyridoxines as anti-platelet agents
JP2008517956A (ja) * 2004-10-28 2008-05-29 メディキュア・インターナショナル・インコーポレーテッド 二重の抗血小板性／抗凝固性ピリドキシン類似体
US7459468B2 (en) * 2004-10-28 2008-12-02 Medicure International, Inc. Aryl sulfonic pyridoxines as antiplatelet agents
US20070149485A1 (en) * 2005-11-28 2007-06-28 Medicure International, Inc. Selected dosage for the treatment of cardiovascular and related pathologies

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54109996A (en) * 1977-11-25 1979-08-29 Scras Pridine derivative*manufacture thereof and kidney protection and diuretic composition containing said derivative
JPS57150688A (en) * 1981-02-10 1982-09-17 Do Konseiyu Do Rushierushie E Furo(3,4-c)pyridine derivative, manufacture and medicinal composition containing same

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2008582B (en) * 1977-11-25 1982-04-28 Scras Pyridine derivative

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54109996A (en) * 1977-11-25 1979-08-29 Scras Pridine derivative*manufacture thereof and kidney protection and diuretic composition containing said derivative
JPS57150688A (en) * 1981-02-10 1982-09-17 Do Konseiyu Do Rushierushie E Furo(3,4-c)pyridine derivative, manufacture and medicinal composition containing same

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02504394A (ja) * 1988-04-06 1990-12-13 ソシエテ・ド・コンセイユ・ド・ルシエルシエ・エ・ダアツプリカーシヨン・シヤンテイフイツク・（エス．セー．エール．アー．エス） フロ〔３，４‐ｃ〕ピリジン鏡像体の立体特異的製造方法、かくして得られた化合物及びこれの製薬組成物

Also Published As

Publication number Publication date
SE8401841D0 (sv) 1984-04-03
DK157931C (da) 1990-08-27
IL71243A (en) 1987-12-20
OA07699A (fr) 1985-08-30
FI841273L (fi) 1984-10-06
PT78361B (en) 1986-05-28
DE3412885C2 (de) 1990-10-04
CA1257269A (en) 1989-07-11
ES8601998A1 (es) 1985-11-01
NO841322L (no) 1984-10-08
FR2543829B1 (fr) 1986-11-21
KR840008651A (ko) 1984-12-17
FR2543956A1 (fr) 1984-10-12
EG18150A (en) 1992-08-30
PT78361A (en) 1984-05-01
AU582113B2 (en) 1989-03-16
NL190328C (nl) 1994-01-17
KR900005518B1 (ko) 1990-07-30
DK178084D0 (da) 1984-04-04
NO161802B (no) 1989-06-19
SE8401841L (sv) 1984-10-06
JPH0556353B2 (enExample) 1993-08-19
HK11187A (en) 1987-02-13
AU2640184A (en) 1984-10-11
IE57424B1 (en) 1992-09-09
LU85262A1 (fr) 1984-10-24
US4581363A (en) 1986-04-08
DZ629A1 (fr) 2004-09-13
IT1173770B (it) 1987-06-24
SE458362B (sv) 1989-03-20
MY8600664A (en) 1986-12-31
DK157931B (da) 1990-03-05
IT8420396A0 (it) 1984-04-05
CH660191A5 (fr) 1987-03-31
IE840826L (en) 1984-10-05
FI76804C (fi) 1988-12-12
FR2543829A1 (fr) 1984-10-12
IN160104B (enExample) 1987-06-27
IL71243A0 (en) 1984-06-29
FR2543956B1 (fr) 1986-07-04
GR79577B (enExample) 1984-10-30
MX167397B (es) 1993-03-22
NL190328B (nl) 1993-08-16
FI76804B (fi) 1988-08-31
FI841273A0 (fi) 1984-03-30
NO161802C (no) 1989-09-27
MA20084A1 (fr) 1984-12-31
NL8401013A (nl) 1984-11-01
DK178084A (da) 1984-10-06
NZ207552A (en) 1986-05-09
DE3412885A1 (de) 1984-10-11
ES531285A0 (es) 1985-11-01

Similar Documents

Publication Publication Date Title
JPS59193888A (ja) フロ−（３，４−ｃ）−ピリジン誘導体、その製造法及びそれを含有する医薬
CA1175837A (en) Furo-(3,4-c)-pyridine derivatives, process of preparation of the same and therapeutical composition containing the same
JP2004531516A (ja) 新規ベンジリデンアミノグアニジンおよびそれらのメラノコルチンレセプターリガンドとしての使用方法
US4735950A (en) Furo-(3,4-C)-pyridine derivatives and therapeutic composition containing the same
BR0113078A (pt) Uso de um composto, composto, processo para a preparação do mesmo, composição farmacêutica, e, método para produzir um efeito antiangiogênico e/ou redutor da permeabilidade vascular em um animal de sangue quente
TWI324066B (en) A pharmaceutical composition for inhibiting cell migration induced by an angiogenic factor
JPH0317046A (ja) アリールオキシフエニルプロピルアミン、その製造方法及びその使用方法
JP2007532670A (ja) Ｒ（−）−１１−ヒドロキシアポルフィン誘導体およびその使用方法
JPH07233065A (ja) ピリリウム塩又はピリリウム類似塩を含む光化学治療薬
CN106866572A (zh) 一氧化氮供体型β‑榄香烯衍生物及其制备方法和用途
CN102066362A (zh) 二氢吲哚酮衍生物
EP0038343A1 (de) Substituierte oxocarbonsäuren, verfahren zu ihrer herstellung, ihre verwendung und sie enthaltende arzneimittel.
CN108084153A (zh) 吡啶基硫代乙酸化合物、组合物及其应用
KR100251395B1 (ko) 피소스티그민 유도체와 이의 용도 및 이를 함유한 제약적 조제물
RU2427368C1 (ru) Антиаритмическое средство на основе 4-метил-7,7'-этилендиокси-2н-1-дибензопиран-2,2'-диона
CN102212058B (zh) “单一的复合药”：手性含氮杂环酯、合成法及其在制备低毒性cb1受体抑制剂中的应用
CN102382032A (zh) 1-(苯基)-4-[3-(4-吲哚氧基)-2-羟基丙基]哌嗪衍生物及其盐、制备方法和应用
US20030078284A1 (en) Materials and methods for the treatment of depression
WO2023230038A1 (en) Piperidinyl-methylpurine pyrimidines and related compounds and their use in treating diseases and conditions
JPH05502867A (ja) ピペリジン化合物及び医薬組成物
JPH0339513B2 (enExample)
NL8200491A (nl) 17, 18-dehydroapovincaminol-3'4',5'-trimethoxybenzoaat, de zuuradditiezouten ervan, tussenprodukten, alsmede werkwijzen ter bereiding van deze verbindingen.
CN109912681A (zh) 含有环戊烷并多氢菲类骨架的衍生物及其在制备防治梗死性疾病的药物中的应用
CN101691351B (zh) 4-胺基丙烯基苯基-1,4-二氢吡啶类的合成及其药物用途
JPS61158968A (ja) フエナシル誘導体